@medexplained2you's men's health advice, fact-checked
Quick answer
The video recommends annual testosterone screening for all men, citing age-related decline, but current Endocrine Society guidelines limit testosterone testing to symptomatic men with clinical signs of hypogonadism. Prostate cancer screening via PSA carries a complex benefit-harm profile acknowledged by the USPSTF, which assigns it only a conditional recommendation for men aged 55-69. The mental health recommendation is the most straightforwardly supported claim in the video, given documented disparities in men's mental health service utilization and associated outcomes.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @medexplained2you actually say?
The creator laid out three health priorities for men during Men's Health Month: get testosterone levels checked yearly, see a mental health specialist, and get a prostate check. The framing was upbeat and general, aimed at guys who probably haven't thought much about any of this. The creator also made a reasonable closing point: all of this flows through having a primary care provider you actually see.
On testosterone, they said "everyone knows about menopause, but not everyone knows about andropause" and that levels "can drop" with age, warranting yearly screening. On prostate, they called it "the second most common cancer in men worldwide" and described it as "highly treatable and easy to check for." These are the specific claims worth examining, because the devil is in the details here.
Does the science back this up?
Partially. The mental health point is well-supported and the general message about primary care is solid. But the testosterone and prostate claims need more precision than this video offers.
On testosterone: yes, levels decline with age. The Massachusetts Male Aging Study (Feldman et al., 2002, Journal of Clinical Endocrinology and Metabolism) found total testosterone declines roughly 1.6% per year after age 40. But "andropause" is a contested label. Unlike menopause, the testosterone decline in men is gradual, not universal, and doesn't always produce symptoms. The Endocrine Society's 2018 clinical guidelines explicitly state that testosterone testing should be reserved for men with signs and symptoms of hypogonadism, not as a routine population screen. Yearly screening for all men isn't currently supported by major clinical guidelines.
On prostate: the "second most common cancer" stat checks out (Sung et al., 2021, CA: A Cancer Journal for Clinicians). But "easy to check for" is doing a lot of work. PSA screening is genuinely controversial. The U.S. Preventive Services Task Force gives PSA screening a Grade C recommendation for men 55-69, meaning the benefit-harm balance is close enough that it's a personal decision, not a blanket recommendation.
What did they get wrong (or right)?
The mental health section is the strongest part of the video. The claim that men have been "taught that showing emotion is bad" and that this is unhealthy is supported by substantial research. Men consistently underutilize mental health services, and that gap has real mortality consequences (Seidler et al., 2016, Clinical Psychology Review). No complaints here.
The testosterone section oversimplifies in a meaningful way. Recommending yearly testing "with your primary care doctor" for all men implies there's a screening benefit that guidelines don't actually support. Routine testosterone screening in asymptomatic men isn't recommended by the American Urological Association, the Endocrine Society, or the American College of Physicians. Testing makes sense when symptoms are present, such as fatigue, low libido, or mood changes, but framing it as something every man should just be doing annually is a stretch.
The prostate section gets the prevalence stat right but glosses over the real complexity of screening decisions. Saying it's "easy to check for" isn't wrong exactly, but it sidesteps the real clinical debate about overdiagnosis and overtreatment that has surrounded PSA screening for two decades. That omission matters when you're giving health advice to a general audience.
What should you actually know?
If you're experiencing symptoms that could point to low testosterone, such as fatigue, reduced libido, difficulty concentrating, or mood shifts, then yes, get tested. That's appropriate and your doctor can interpret results in context. But don't walk into your doctor's office demanding a testosterone panel just because you watched a Men's Health Month video. Testosterone testing without clinical indication is unlikely to be covered by insurance and may lead to treatment decisions based on numbers rather than how you actually feel.
On prostate screening, have the conversation with your doctor, especially if you're over 50 or have a family history of prostate cancer or are Black, a demographic with significantly higher prostate cancer risk (Rebbeck et al., 2013, Journal of the National Cancer Institute). The PSA test exists and can be useful, but it's a conversation, not an automatic yearly box to check.
The mental health recommendation is the most actionable and least controversial advice in the video. If you haven't talked to anyone in years about how you're actually doing, that's probably the most evidence-based thing you can do for your long-term health.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @medexplained2you's men's health advice, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@medexplained2you's men's health advice, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video recommends annual testosterone screening for all men, citing age-related decline, but current Endocrine Society guidelines limit testosterone testing to symptomatic men with clinical signs of hypogonadism.
FormBlends verdict
The video recommends annual testosterone screening for all men, citing age-related decline, but current Endocrine Society guidelines limit testosterone testing to symptomatic men with clinical signs of hypogonadism. Prostate cancer screening via PSA carries a complex benefit-harm profile acknowledged by the USPSTF, which assigns it only a conditional recommendation for men aged 55-69. The mental health recommendation is the most straightforwardly supported claim in the video, given documented disparities in men's mental health service utilization and associated outcomes.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video recommends annual testosterone screening for all men, citing age-related decline, but current Endocrine Society guidelines limit testosterone testing to symptomatic men with clinical signs of hypogonadism. Prostate cancer screening via PSA carries a complex benefit-harm profile acknowledged by the USPSTF, which assigns it only a conditional recommendation for men aged 55-69. The mental health recommendation is the most straightforwardly supported claim in the video, given documented disparities in men's mental health service utilization and associated outcomes.
- Testosterone declines approximately 1-2% per year after age 40, but routine screening in asymptomatic men is not recommended by the Endocrine Society or American Urological Association.
- The Endocrine Society's 2018 guidelines reserve testosterone testing for men with clinical symptoms such as fatigue, low libido, or mood changes, not as a general annual panel.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone declines approximately 1-2% per year after age 40, but routine screening in asymptomatic men is not recommended by the Endocrine Society or American Urological Association.
- The Endocrine Society's 2018 guidelines reserve testosterone testing for men with clinical symptoms such as fatigue, low libido, or mood changes, not as a general annual panel.
- Prostate cancer is the second most common cancer in men globally (Sung et al., 2021), but PSA screening is a shared decision between patient and physician, not a universal annual requirement, per USPSTF guidance.
- Men in the U.S. are significantly less likely to seek mental health care than women, and that gap is associated with worse outcomes including higher suicide rates (Seidler et al., 2016, Clinical Psychology Review).
- Black men face substantially higher prostate cancer incidence and mortality rates, making earlier and more active screening conversations appropriate for that demographic specifically.
- If testosterone symptoms are present, testing is appropriate and clinically supported. If no symptoms exist, an annual testosterone check adds limited value and may not be covered by insurance.
- The strongest, least controversial recommendation in this video is the mental health one. The prostate and testosterone advice would benefit from more nuance about when screening is actually indicated.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Med Explained 2 You, LLC · TikTok creator
12.5K views on this video
Hey guys, June is Men's Health Month! 💪🏼 Level up your health game with testosterone level checks, mental health awareness, and regular prostate checks. Remember, your health is in your hands. @ymyh
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Med Explained 2 You, LLC, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.